openPR Logo
Press release

Lewy Body Dementia Treatment Market Driven by Surging Cholinesterase Inhibitor Sales, Fact.MR Study

04-04-2019 02:25 PM CET | Health & Medicine

Press release from: Fact.MR

Lewy Body Dementia Treatment Market Driven by Surging

According to a latest research study by Fact.MR the global lewy body dementia treatment market is projected to surpass US$ 3,650 Mn in 2019, up from nearly 3,500 Mn in 2018. Broader factors concerning the healthcare industry, especially renewed focus on managing geriatric and mental health issues, are likely to impact growth of lewy body dementia treatment market.

Cholinesterase inhibitors will remain the topselling drugs for treating lewy body dementia, accounting for nearly 60% share in 2018. The demand for cholinesterase inhibitors will be followed by antipsychotic drugs owing to their minimal side effects in management of lewy body dementia.

The study opines that macro-economic factors, including growing geriatric population, increasing per capita healthcare expenditure, and paradigm shift towards a value-based healthcare model will drive market growth. Increasing healthcare spending has the potential to directly impact the need for lewy body dementia diagnostics and treatment solutions, which, in turn, will create growth opportunities for stakeholders in the market.

Request For a Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1154

As per the study, the funding for research and investments in drugs has increased significantly, owing to the increasing prevalence of mental health issues, especially in elderly population. According to the study, increase in the number of on-going clinical trials will pave way for more effective lewy body dementia treatment over existing options.

The adoption of drug manufacturing processes will lead to enhanced lewy body dementia treatment procedures. Moreover, the growing research and development initiatives in lewy body dementia treatment market will boost the efficiency of the existing lewy body dementia treatment choices, which in turn, will aid stakeholders in appealing to a wider consumer base.

Read 170 page research report with TOC on "Lewy Body Dementia Treatment Market Size, Share & Trends Analysis Report By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Carbidopa-Levodopa, Antidepressants, Benzodiazepine, Modafinil), By Indication (Dementia with Lewy Bodies, Parkinson’s Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), & By Region And Segment Forecasts, 2018 - 2028" at: https://www.factmr.com/report/1154/lewy-body-dementia-treatment-market

According to the study, the growing healthcare facilities in developing countries, with a high prevalence of lewy body dementia, are creating lucrative growth opportunity for key pharmaceutical companies. Key players in lewy body dementia treatment market are adopting unique strategies, such as capacity expansion, novel product launches, and adoption of innovation-driven products, to increase the sales of their offerings in diverse geographies. Additionally, companies in lewy body dementia treatment market are entering into strategic alliances with other pharmaceutical companies and government bodies for faster development of present pipeline drugs.

North America to Remain Most Lucrative Market for Lewy Body Dementia Treatment

According to the Fact.MR study, North America is likely to account for nearly one-third share of the market. This can be attributed to the rapid shift in demand for lewy body dementia treatment in developed economies, which have progressive healthcare sector and healthy reimbursement scenario for expensive drug cost. Furthermore, the easy accessibility for such treatment due to the presence of concerned healthcare professionals is driving growth in North America lewy body dementia treatment market. The study anticipates East Asia to be the second lucrative market for lewy body dementia treatment, following North America.

Have Any Query? Ask our Industry Expert- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1154

As per the study, Brazil and China will remain highly promising markets in terms of upcoming collaborative research in lewy body dementia treatment, mainly in the pharmaceutical industry. The leading stakeholders in lewy body dementia treatment market are focusing on increasing their market share in the Asia Pacific market through strategic mergers and acquisition with regional players and investment groups, finds the study. Whereas, regional market players are building long-term relationships with direct end-users to sustain continuous revenue flow.

The Fact.MR report analyses latent growth opportunities in the lewy body dementia treatment market from 2018 to 2028. As per the research study, the lewy body dementia treatment is likely to accelerate at a value CAGR of more than 4.5% during the foreseeable period.

To Buy Lewy Body Dementia Treatment Market Report, Check- https://www.factmr.com/checkout/1154/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read News at- https://theswisstimes.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lewy Body Dementia Treatment Market Driven by Surging Cholinesterase Inhibitor Sales, Fact.MR Study here

News-ID: 1688439 • Views:

More Releases from Fact.MR

Robot Arms Market is Anticipated to Reach US$ 77.2 Billion by 2033
Robot Arms Market is Anticipated to Reach US$ 77.2 Billion by 2033
According to Fact.MR, a market research and competitive intelligence provider, the global robot arms market is estimated to be valued at USD 26.2 billion in 2023 and is expected to expand at an impressive CAGR of 11.4% during the forecast period. The use of robot arms is increasing across diverse industries such as manufacturing, healthcare, logistics, supply chain, and retail. With the growing integration of technologies like machine learning and artificial
Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million By 2034
07-19-2024 | Food & Beverage
Fact.MR
Mechanically Separated Poultry Market Is Projected To A Colossal $255.9 Million …
It is anticipated that the global mechanically separated poultry market would reach US$ 160.4 million by 2024. By the end of 2034, the mechanically separated poultry market is expected to grow at a 4.8% CAGR and be worth US$ 255.9 million worldwide. The mechanically separated poultry (MSP) market has seen consistent growth over recent years, driven by increasing demand for cost-effective meat products and advancements in food processing technologies. This
Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By 2034
07-19-2024 | Food & Beverage
Fact.MR
Glucose Management Supplement Market Is Expected To A Colossal $17.5 Billion By …
The estimated worth of the global glucose management supplement market is expected to rise from US$ 9.7 billion in 2024 to US$ 17.5 billion by the end of 2034. It is true.Sales of glucose management supplements are expected to increase at a compound annual growth rate (CAGR) of 6.1% between 2024 and 2034, according to MR's most recent analysis. The glucose management supplement market has seen significant growth in recent years,
Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
07-19-2024 | Food & Beverage
Fact.MR
Rosehip Market Is Expanding Estimated To A Colossal $486.7 Million By 2034
The revenue from the global rosehip market is expected to grow at a 5.6% CAGR from 2024 to 2034, from a value of US$ 282.6 million in 2024 to US$ 486.7 million by the end of that year. The Rosaceae family includes the herbal medicine made from rosehips. This wild rose variety, also called Rosa canina, grows well in many parts of Asia, Africa, and Europe. After fertilization, rosehips, the

All 5 Releases


More Releases for Lewy

08-13-2021 | Health & Medicine
Fact.MR
Antipsychotic Drugs For Lewy Body Dementia Treatment Market Forecast and Trends …
Lewy Body Dementia Treatment Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Lewy Body Dementia
Lewy Body Dementia Drugs Market Opportunities And Analysis By Size, Share, Trend …
The global Lewy Body Dementia Drugs market 2020 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Lewy Body Dementia Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well
Lewy Body Dementia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Resu …
Lewy body dementia is a progressive brain disorder in which Lewy bodies build up in different parts of the brain that regulate cognition, movement and behavior. Lewy bodies are abnormal deposition of a protein called alpha-synuclein. Download the sample report @ https://www.pharmaproff.com/request-sample/1104 The symptoms associated with the Lewy body dementia includes memory and thinking problems; moving problems; and sleeping and behavioral changes. It can be treated by medications, physical therapy, speech
Global Lewy Body Dementia Treatment Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Global Lewy Body Dementia Treatment Market Research Report 2018 to its huge collection of research reports. The Global Lewy Body Dementia Treatment market has been thoroughly studied, researched and detailed on in this publication by taking the assistance of advanced secondary and primary research that has been performed by the best of analysts and by making use of the best of the available techniques. The
Asia-Pacific Lewy Body Dementia Treatment Market Moving Towards a Brighter Futur …
Worldwide Market Reports added Latest Research Report titled ” Asia-Pacific Lewy Body Dementia Treatment Market Report 2018 ” to its Large Report database. In this report, the Asia-Pacific Lewy Body Dementia Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split Asia-Pacific into several key
Global Lewy Body Dementia Treatment Market 2018- BioArctic AB, Eisai Co., Ltd., …
Apex Market Reports, recently published a detailed market research study focused on the "Global Lewy Body Dementia Treatment Market" across the global, regional and country level. The report provides 360° analysis of "Global Lewy Body Dementia Treatment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the Global Lewy Body Dementia Treatment industry, and